Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymph Node FNA to Study Pneumococcal Vaccine Immunity
NCT06202703Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Prevnar 13 in pneumococcal disease, sponsored by Leiden University Medical Center. Primary endpoint: Peak Germinal Center B Cell Count at 3 months. Started Apr 2023; status: recruiting.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT06202703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06202703.